Monday, July 17, 2023 Daily Archives

Voices of Biotech: CGT Circle talks female networking

by

The three founders of the CGT Circle discuss the importance of decentralized networking for women and why the network was created. In the latest episode of Voices of Biotech, brought to you by the BioProcess Insider Expression Platform, editor of BioProcess Insider Mille Nelson sits down with the three founding members of the CGT Circle. They discuss the demand for local community led networking, leading them to launch their platform which aims to create “decentralized networking” for women in the…

July 17, 2023

Lilly going bigger on obesity with Versanis buy

by

Eli Lilly will pay up to $1.925 billion to acquire biotech Versanis, adding its Phase II obesity candidate bimagrumab to its pipeline. Bimagrumab is a monoclonal antibody developed by Versanis that binds activin type II A and B receptors to block activin and myostatin signaling. The candidate is in Phase II clinical trials both as a standalone drug and in combination with the antidiabetic peptide semaglutide for obesity. Development will now be taken over by Eli Lilly, which is set…

July 17, 2023

GBI: AI will change the CDMO landscape, but not without trained staff

by

AI could change the CDMO landscape but there is a lack of data scientists who have the required training, says GBI Biomanufacturing. With more CDMOs looking into digital technologies as a solution to manufacturing challenges, Amita Quadros, vice president of commercial operations at GBI Biomanufacturing told BioProcess Insider at BIO in Boston “AI will change the whole landscape of how CDMOs operate in the future.” GBI Biomanufacturing is a Florida-based biopharmaceutical CDMO, which has been operating since 1992. Quadros said…

July 17, 2023